100 Participants Needed

Local Anesthesia for Vaginal Lacerations

(PAIN Trial)

Recruiting at 1 trial location
CP
FE
FE
AM
Overseen ByAlyssa M Yeung, MD
Age: 18+
Sex: Female
Trial Phase: Phase 4
Sponsor: Montefiore Medical Center
Must be taking: Epidural analgesia
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)
Prior Safety DataThis treatment has passed at least one previous human trial
Approved in 3 JurisdictionsThis treatment is already approved in other countries

What You Need to Know Before You Apply

What is the purpose of this trial?

This trial tests a new method to manage pain for women who have just given birth and require stitches for vaginal tears. Researchers aim to determine if using a local anesthetic, bupivacaine with epinephrine, can reduce pain and improve satisfaction compared to a regular saline solution. The study includes women with a working epidural during their repair who have not experienced complications like heavy bleeding or extreme pain. Participants should speak English or Spanish and have had a single baby. The goal is to help new mothers feel better and reduce the need for stronger pain medications. As a Phase 4 trial, this research involves an FDA-approved treatment and seeks to understand its benefits for more patients.

Do I need to stop my current medications for this trial?

The trial protocol does not specify whether you need to stop taking your current medications, so it's best to discuss this with the trial coordinators or your doctor.

What is the safety track record for Bupivacaine with Epinephrine?

Research shows that bupivacaine with epinephrine is generally safe for people. It often numbs areas during surgery, childbirth, and dental work, indicating its frequent use in similar situations. Studies have found it is usually well-tolerated, especially in childbirth-related care, with few side effects reported in these settings.

However, specific information on its effects on a baby's development during pregnancy is lacking. Doctors do not fully understand its impact on a baby's growth when used during pregnancy. Overall, existing evidence suggests it is safe for most people.12345

Why are researchers enthusiastic about this study treatment?

Researchers are excited about using bupivacaine with epinephrine for treating vaginal lacerations because it offers a longer-lasting anesthesia effect compared to standard treatments like lidocaine. Bupivacaine is known for its prolonged duration of pain relief, which can be particularly beneficial in managing discomfort from lacerations. The addition of epinephrine helps to minimize bleeding and prolongs the anesthetic effect by constricting blood vessels. This combination could offer better pain management and efficiency in clinical settings, making it a promising option for improving patient care.

What evidence suggests that bupivacaine with epinephrine is effective for postpartum perineal pain?

In this trial, participants in the local anesthesia arm will receive bupivacaine with epinephrine. Research shows this combination effectively numbs the area during cuts or tears that need stitching. Bupivacaine stops pain, while epinephrine prolongs its effect by slowing blood flow at the application site. Studies indicate that adding epinephrine extends pain relief duration, which is beneficial after childbirth. Bupivacaine is already widely used in surgeries to numb specific areas, suggesting it could also manage pain post-childbirth. This treatment has reduced the need for opioid painkillers, helping to avoid their side effects or risk of dependency.12467

Who Is on the Research Team?

FE

Fatima Estrada, MD, FACOG

Principal Investigator

Montefiore Medical Center

Are You a Good Fit for This Trial?

This trial is for healthy women over 18 who've had a single baby delivered vaginally, resulting in a second-degree perineal tear. They must speak English or Spanish and be able to consent for themselves. It's not specified who can't join.

Inclusion Criteria

My epidural is working during my laceration repair.
Healthy with a singleton pregnancy
I can make my own medical decisions.

Exclusion Criteria

Allergic to bupivacaine and/or epinephrine
I received a combined spinal-epidural anesthesia.
Multiple gestation
See 4 more

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

1 week

Treatment

Participants receive either bupivacaine with epinephrine or a saline sham injection for perineal laceration repair

Immediate
1 visit (in-person)

Immediate Follow-up

Participants' pain levels and time to first analgesic demand are assessed immediately and up to 24 hours after treatment

24 hours
Continuous monitoring

Follow-up

Maternal satisfaction and pain levels are assessed 48 hours after treatment

48 hours
1 visit (in-person or virtual)

What Are the Treatments Tested in This Trial?

Interventions

  • Bupivacaine with Epinephrine
Trial Overview The study tests if injecting bupivacaine with epinephrine reduces pain better than a fake (saline) injection after epidural anesthesia wears off post-vaginal delivery. Women are randomly assigned to either the real drug or sham treatment without knowing which one they receive.
How Is the Trial Designed?
2Treatment groups
Experimental Treatment
Placebo Group
Group I: Local Anesthesia armExperimental Treatment2 Interventions
Group II: Normal saline sham armPlacebo Group1 Intervention

Bupivacaine with Epinephrine is already approved in United States, European Union, Canada for the following indications:

🇺🇸
Approved in United States as Bupivacaine with Epinephrine for:
🇪🇺
Approved in European Union as Bupivacaine with Epinephrine for:
🇨🇦
Approved in Canada as Bupivacaine with Epinephrine for:

Find a Clinic Near You

Who Is Running the Clinical Trial?

Montefiore Medical Center

Lead Sponsor

Trials
468
Recruited
599,000+

Published Research Related to This Trial

In a randomized, double-blind study comparing 1% lidocaine with epinephrine to 0.5% bupivacaine with epinephrine for facial plastic surgery, bupivacaine demonstrated effective and safe anesthesia.
Bupivacaine, being a longer-acting local anesthetic, may provide better surgical conditions compared to lidocaine, making it a suitable choice for facial procedures.
Lidocaine v bupivacaine in facial plastic surgery. A clinical trial.Maimon, WN., Schuller, DE.[2022]
In a study involving 30 patients, two forms of 0.5% bupivacaine hydrochloride (Anecaine and Marcaine) were compared for epidural anesthesia, revealing differences in how quickly and effectively they provided pain relief.
Anecaine showed a shorter onset of analgesia at the catheter site but a delayed effect in peripheral areas compared to Marcaine, indicating that even the same active ingredient can behave differently based on the manufacturer.
[A clinical trial of the use of 2 forms of bupivacaine hydrochloride (Anecaine and Marcaine) for epidural anesthesia].Kozlov, SP., Vashchinskaia, TV., Svetlov, VA.[2013]
In a study involving 90 children with mucous membrane lacerations, the traditional lidocaine infiltration was found to be significantly more effective than the new topical anesthetic TetraLidoPhen in reducing pain during suturing, as measured by various pain scales.
Despite TetraLidoPhen being statistically inferior to lidocaine, it was deemed safe for use on mucous membranes, with a low wound complication rate of 4.4%, suggesting that further research is needed to fully assess its clinical utility.
Tetracaine-lidocaine-phenylephrine topical anesthesia compared with lidocaine infiltration during repair of mucous membrane lacerations in children.Smith, GA., Strausbaugh, SD., Harbeck-Weber, C., et al.[2017]

Citations

Local Anesthesia for Vaginal Lacerations (PAIN Trial)Research shows that bupivacaine with epinephrine is effective in providing local anesthesia during laceration repairs, as it has a longer duration of action ...
MARCAINE WITH EPINEPHRINE- bupivacaine hydrochloride ...Use the lowest dosage of MARCAINE / MARCAINE WITH EPINEPHRINE that results in effective anesthesia to avoid high plasma levels and serious adverse effects.
Marcaine Bupivacaine Hydrochloride injection labelThe duration of anesthetic effect is prolonged by the addition of epinephrine 1:200,000. Local anesthetics are bound to plasma proteins in varying degrees.
PMCWe randomized 27 women undergoing open gynecological surgery to receive either three XaraColl implants (each containing 50 mg bupivacaine hydrochloride) or ON-Q ...
Side-by-Side Product Comparison of Bupivacaine ...Bupivacaine is indicated in any type of peripheral anesthesia. • Local infiltration to nerve trunk, regional block. • Symphathetic nerve block.
Bupivacaine and epinephrine (injection route)Bupivacaine and epinephrine combination injection is used to numb an area of your body during surgery or other procedures, childbirth, or dental work.
Marcaine - Drug SummaryBupivacaine's onset of action is rapid (2 to 10 minutes), and it is significantly longer lasting than other commonly used local anesthetics.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Terms of Service·Privacy Policy·Cookies·Security